Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral Cardiomyopathy

2 MIU per application in week 1 and 4 MIU per application in weeks 2 to 24 given subcutaneously every other day

2 MIU per application in week 1, 4 MIU per application in weeks 2 to 3 and 8 MIU per application in weeks 4 to 24 given subcutaneously every other day

0.25 ml in week 1 and 0.50 ml in weeks 2 to 24 given subcutaneously every other day

0.25 ml in week 1, 0.50 ml in weeks 2 to 3 and 1.00 ml in weeks 4 to 24 given subcutaneously every other day